Teva to Buy Allergan Plc's Generic Drugs Unit for $40.5 Billion

$40.5 billion acquisition will turn Israeli company into one of world’s biggest drugmakers; Teva shares rally while Mylan plunges.

Yoram Gabison
TheMarker
Send in e-mailSend in e-mail
Teva's factory in Hungary.Credit: Bloomberg

Comments